FirstWord HealthTech

Blood test taps into lung cancer's molecular makeup to track changes

StimCardio raises $30M to test at-home nerve stimulation after AF ablation

StimCardio raised $30 million in series A to advance a wrist-worn treatment, du...

Inklings of a turnaround at Teladoc as Q3 loss narrows

Teladoc Health may finally be turning a corner after reporting stronger-than-ex...

Oura launches study to probe wearables' role in GLP-1 treatment, bariatric surgery

Oura is putting its wearables to the test in a new clinical trial exploring ho...

Brainomix's AI software flags potential responders to Remedy's stroke drug

A post-hoc analysis of a Phase III stroke trial suggests Brainomix's AI-powere...

Enveda, Anthropic take aim at drug-development bottlenecks with Claude

Enveda is teaming up with

ESMO26: Ultima Genomics' whole-genome assay flags lung cancer relapse risk

An ultrasensitive blood test identified lung cancer patients at substantially h...

Genomate Health, VivaMed seek to revive shelved cancer drugs with AI

Genomate Health and VivaMed BioPharma are teaming up to find new uses for exist...

AI models more likely to recommend brand-name drugs over generics: study

Popular large language models (LLMs) tend to favour brand-name drugs and medic...

ESMO26: AI models mine routine health data to predict cancer risk

Machine learning models using routine health data could help identify people a...

ESMO26: DTx boosts insomnia remission in women with cancer

Digital cognitive behavioural therapy more than doubled insomnia remission rate...

NICE proposes NHS funding for five AI tools to detect prostate cancer

Five AI technologies could be used across England's National Health Service (NH...

Beacon Biosignals nabs Snap Diagnostics in bid to widen at-home sleep testing

Beacon Biosignals has scooped up home sleep test provider Snap Diagnostics, mo...

Boehringer Ingelheim teams up with Microsoft on digital patient twins

Boehringer Ingelheim has added Microsoft to its roster of AI partners as it ex...

Merck enlists NVIDIA, Microsoft to develop AI companion for cancer patients

Merck KGaA is working with NVIDIA, Microsoft and Dawn Health to develop a round...

PerturbAI, OpenAI mine brain CRISPR data for drug discovery leads

PerturbAI and partner OpenAI on Wednesday peeled back the curtain on an approac...

FDA finalises playbook for prescription drug apps

The FDA has laid out its final guidance on apps that accompany prescription me...

Labcorp to buy Myriad Genetics' prenatal testing business for $210M

Shares of Myriad Genetics soared nearly 40% on Tuesday after the company annou...

Pacific Biosciences, Verily to link long-read sequencing with clinical data for AI training

PacBio and Verily Health entered a multi-year collaboration Monday to combine d...

Lilly taps METiS TechBio for $1.1B+ to put AI behind nanoparticle delivery

Eli Lilly is partnering with METiS TechBio to develop lipid nanoparticles (LNPs...